CSPN Share Price Performance
CA$0.02
-0.01 (-33.33%)
Price CA$0.02
Share PriceCA$0.02
CareSpan Health, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
CSPN Community Narratives
There are no narratives available yet.
Recent CSPN News & Updates
CareSpan Health, Inc. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.011
- Gross Margin
- -93.14%
- Net Profit Margin
- -89.92%
- Debt/Equity Ratio
- -11.4%
CareSpan Health, Inc. Competitors
Snowflake Analysis
About CSPN
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
CareSpan Health, Inc., together with its subsidiaries, operates as a healthcare technology and services company in the United States. The company offers CareSpan Clinic, a clinical workflow-driven platform that integrates remote patient monitoring, diagnostic tools, patient electronic health records, care collaboration capabilities, patient engagement, e-prescribing, and lab ordering, as well as deliver primary and urgent care, and behavioral health care. It is also involved in technology development and licensing activities; and provides management services. The company is headquartered in New York, New York.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.S. Market Performance
- 7 Days: 0.3%
- 3 Months: 8.5%
- 1 Year: 17.3%
- Year to Date: 15.0%
In the last week, the market has been flat. As for the longer term, the market has risen 17% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›